CLINICAL_TRIALS
trial_result
· 2014-02-26
Clinical Trial Update: Long Term Administration Study of OPC-12759 Ophthalmic Suspension [Phase 3]
Summary
Phase 3 long-term study of OPC-12759 ophthalmic suspension for dry eye disease has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2014-02-26